Literature DB >> 16618472

The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.

Nicola Torrance1, Blair H Smith, Michael I Bennett, Amanda J Lee.   

Abstract

UNLABELLED: Progress in the understanding of chronic pain with neuropathic features has been hindered by a lack of epidemiologic research in the general population. The Leeds Assessment of Neuropathic Symptoms and Signs score (S-LANSS) was recently validated for use in postal surveys, making the identification of pain of predominantly neuropathic origin possible. Six family practices in 3 UK cities (Aberdeen, Leeds, and London) generated a total random sample of 6,000 adults. The mailed questionnaire included demographic items, chronic pain identification, and intensity questions, the S-LANSS, the Level of Expressed Needs questionnaire, and the Neuropathic Pain Scale. With a corrected response rate of 52%, the prevalence of any chronic pain was 48% and the prevalence of pain of predominantly neuropathic origin was 8%. Respondents with this chronic neuropathic pain were significantly more likely to be female, slightly older, no longer married, living in council rented accommodation, unable to work, have no educational qualifications, and be smokers than all other respondents. Multiple logistic regression modeling found that pain of predominantly neuropathic origin was independently associated with older age, gender, employment (being unable to work), and lower educational attainment. Respondents with this pain type also reported significantly greater pain intensity, higher scores on the NPS, higher levels of expressed need, and longer duration of pain. This is the first estimate of the prevalence and distribution of pain of predominantly neuropathic origin in the general population, using a previously validated and reliable data collection instrument. PERSPECTIVE: Chronic pain with neuropathic features appears to be more common in the general population than previously suggested. This type of pain is more severe than other chronic pain but distributed similarly throughout sociodemographic groups.

Entities:  

Mesh:

Year:  2006        PMID: 16618472     DOI: 10.1016/j.jpain.2005.11.008

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  280 in total

1.  Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.

Authors:  Molly S Crowe; Emma Leishman; Matthew L Banks; Ramesh Gujjar; Anu Mahadevan; Heather B Bradshaw; Steven G Kinsey
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

Review 2.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 3.  Combination pharmacotherapy for the treatment of neuropathic pain in adults.

Authors:  Luis Enrique Chaparro; Philip J Wiffen; R Andrew Moore; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

4.  Acute pain after total hip arthroplasty does not predict the development of chronic postsurgical pain 6 months later.

Authors:  Hance Clarke; Joseph Kay; Nicholas Mitsakakis; Joel Katz
Journal:  J Anesth       Date:  2010-05-19       Impact factor: 2.078

5.  Can pictorial images communicate the quality of pain successfully?

Authors:  S José Closs; Peter Knapp; Stephen Morley; Catherine Stones
Journal:  Br J Pain       Date:  2015-08

Review 6.  Topical capsaicin (high concentration) for chronic neuropathic pain in adults.

Authors:  Sheena Derry; Andrew Sc Rice; Peter Cole; Toni Tan; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-01-13

Review 7.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

Review 8.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 9.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  CARE Scale-7: Development and Preliminary Validation of a Measure to Assess Factors Impacting Self-Care in Chronic Pain.

Authors:  Maisa Ziadni; Dokyoung S You; Anna C Wilson; Beth D Darnall
Journal:  Clin J Pain       Date:  2018-09       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.